Lmo2 expression defines tumor cell identity during T‐cell leukemogenesis

The impact of LMO2 expression on cell lineage decisions during T‐cell leukemogenesis remains largely elusive. Using genetic lineage tracing, we have explored the potential of LMO2 in dictating a T‐cell malignant phenotype. We first initiated LMO2 expression in hematopoietic stem/progenitor cells and maintained its expression in all hematopoietic cells. These mice develop exclusively aggressive human‐like T‐ALL. In order to uncover a potential exclusive reprogramming effect of LMO2 in murine hematopoietic stem/progenitor cells, we next showed that transient LMO2 expression is sufficient for oncogenic function and induction of T‐ALL. The resulting T‐ALLs lacked LMO2 and its target‐gene expression, and histologically, transcriptionally, and genetically similar to human LMO2‐driven T‐ALL. We next found that during T‐ALL development, secondary genomic alterations take place within the thymus. However, the permissiveness for development of T‐ALL seems to be associated with wider windows of differentiation than previously appreciated. Restricted Cre‐mediated activation of Lmo2 at different stages of B‐cell development induces systematically and unexpectedly T‐ALL that closely resembled those of their natural counterparts. Together, these results provide a novel paradigm for the generation of tumor T cells through reprogramming in vivo and could be relevant to improve the response of T‐ALL to current therapies.

[1]  I. Sánchez-García,et al.  Are Leukaemic Stem Cells Restricted to a Single Cell Lineage? , 2019, International journal of molecular sciences.

[2]  K. Welte,et al.  LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis. , 2019, Blood.

[3]  C. Vicente-Dueñas,et al.  Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia , 2019, Front. Cell Dev. Biol..

[4]  Geoffrey Brown,et al.  Modeling the Hematopoietic Landscape , 2019, Front. Cell Dev. Biol..

[5]  S. Karlsson,et al.  A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1 , 2017, Developmental cell.

[6]  Cheng Cheng,et al.  THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA , 2017, Nature Genetics.

[7]  Amir Mehdi. Ansari,et al.  Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments , 2016, Stem Cell Reviews and Reports.

[8]  T. Rabbitts,et al.  LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia , 2016, Leukemia.

[9]  T. Rabbitts,et al.  LMO2 at 25 years: a paradigm of chromosomal translocation proteins , 2015, Open Biology.

[10]  I. Sánchez-García.  How tumour cell identity is established? , 2015, Seminars in cancer biology.

[11]  T. George,et al.  BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia. , 2015, American journal of clinical pathology.

[12]  V. Kouskoff,et al.  Direct Reprogramming of Murine Fibroblasts to Hematopoietic Progenitor Cells , 2014, Cell reports.

[13]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[14]  W. C. Chan,et al.  Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma , 2014, Nature Communications.

[15]  S. Orkin,et al.  Reprogramming Committed Murine Blood Cells to Induced Hematopoietic Stem Cells with Defined Factors , 2014, Cell.

[16]  J. V. van Dongen,et al.  Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia , 2014, Blood Cancer Journal.

[17]  M. Barbacid,et al.  Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.

[18]  R. Sandberg,et al.  Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells. , 2013, Cell stem cell.

[19]  I. Sánchez-García,et al.  Function of oncogenes in cancer development: a changing paradigm , 2013, The EMBO journal.

[20]  X. Chen,et al.  Lmo2 Induces Hematopoietic Stem Cell‐Like Features in T‐Cell Progenitor Cells Prior to Leukemia , 2013, Stem cells.

[21]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[22]  I. Sánchez-García,et al.  p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice , 2013, Cell cycle.

[23]  I. González-Herrero,et al.  Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB , 2012, Cell Cycle.

[24]  A. Ferrando,et al.  The molecular basis of T cell acute lymphoblastic leukemia. , 2012, The Journal of clinical investigation.

[25]  Diego Alonso-López,et al.  A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors , 2012, The EMBO journal.

[26]  I. Lossos,et al.  Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice , 2012, Proceedings of the National Academy of Sciences.

[27]  I. Lossos,et al.  Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma. , 2012, Blood.

[28]  J. Downing,et al.  The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. , 2011, Blood.

[29]  I. Lossos,et al.  LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome , 2011, Haematologica.

[30]  C. Sherr,et al.  Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. , 2011, Blood.

[31]  R. Gilbertson,et al.  Mapping Cancer Origins , 2011, Cell.

[32]  L. Espinosa,et al.  Hes1 expression and CYLD repression are essential events downstream of Notch1 in T-cell leukemia , 2011, Cell cycle.

[33]  M. Hubank,et al.  The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors , 2011, Leukemia.

[34]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[35]  Andrea Califano,et al.  The TLX1 oncogene drives aneuploidy in T-cell transformation , 2010, Nature Medicine.

[36]  A. Statnikov,et al.  The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. , 2010, Cancer cell.

[37]  A. Ashworth,et al.  BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. , 2010, Cell stem cell.

[38]  C. D. de Graaf,et al.  The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal , 2010, Science.

[39]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[40]  M. Piris,et al.  Cancer induction by restriction of oncogene expression to the stem cell compartment , 2008, The EMBO journal.

[41]  R. Shamir,et al.  Regulatory networks define phenotypic classes of human stem cell lines , 2008, Nature.

[42]  Christine Kinnon,et al.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.

[43]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[44]  Eran Segal,et al.  Module map of stem cell genes guides creation of epithelial cancer stem cells. , 2008, Cell stem cell.

[45]  Karin Pike-Overzet,et al.  New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[46]  Govind Bhagat,et al.  Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia , 2007, Nature Medicine.

[47]  M. Busslinger,et al.  Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors , 2007, Nature.

[48]  U. Lendahl,et al.  Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. , 2007, Experimental cell research.

[49]  Rob Pieters,et al.  FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors , 2007, The Journal of experimental medicine.

[50]  A. Ferrando,et al.  The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia , 2007, The Journal of experimental medicine.

[51]  L. Chin,et al.  Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers , 2007, Nature.

[52]  F. Papavasiliou,et al.  Regulation of AID expression in the immune response , 2007, The Journal of experimental medicine.

[53]  I. Lossos,et al.  The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. , 2007, Blood.

[54]  Charles Lee,et al.  The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. , 2006, Blood.

[55]  M. Reth,et al.  Testing gene function early in the B cell lineage in mb1-cre mice , 2006, Proceedings of the National Academy of Sciences.

[56]  J. Aster,et al.  c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. , 2006, Genes & development.

[57]  M. Potapnev,et al.  Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia. , 2005, Experimental oncology.

[58]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Tsien,et al.  Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein , 2004, Nature Biotechnology.

[60]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[61]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[62]  Kathryn A. O’Donnell,et al.  An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets , 2003, Genome Biology.

[63]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[64]  I. Weinstein.  Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.

[65]  M. Busslinger,et al.  Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors , 1999, Nature.

[66]  S. Raimondi,et al.  p27KIP1 deletions in childhood acute lymphoblastic leukemia. , 1999, Neoplasia.

[67]  J. V. van Dongen,et al.  Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. , 1999, Blood.

[68]  S. Orkin,et al.  Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[69]  M. Amylon,et al.  Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions. , 1997, Leukemia research.

[70]  E. Dzierzak,et al.  Expression of the Ly-6E.1 (Sca-1) transgene in adult hematopoietic stem cells and the developing mouse embryo. , 1997, Development.

[71]  M. Greaves,et al.  Rearrangement of immunoglobulin heavy chain genes in human T leukaemic cells shows preferential utilization of the D segment (DQ52) nearest to the J region. , 1986, The EMBO journal.

[72]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[73]  A. Borkhardt,et al.  Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases. , 2017, Cancer research.

[74]  Ash A. Alizadeh,et al.  Transient expression of Bcl 6 is sufficient for oncogenic function and induction of mature B-cell lymphoma , 2015 .

[75]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[76]  I. Lossos,et al.  Identification of LMO 2 transcriptome and interactome in diffuse large B-cell lymphoma , 2012 .

[77]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..